Erratum: Fungal Strategies for Overcoming Host Innate Immune Response (Medical Mycology (2008) 10.1080/13693780802209082);Fungal strategies for overcoming host innate immune response

Medical Mycology

Volumn 47, Issue 3, 2009, Pages 227-236

  Chai, Louis Y A ^a,b   Netea, Mihai G ^a   Vonk, Alieke G ^c   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Escape mechanisms; Innate immunity; Toll like receptor

Indexed keywords

ADHESIN; AGGLUTININ; BETA GLUCAN; DECTIN 1; GLUCAN; GLUCURONOXYLOMANNAN; GLYCOPROTEIN; GLYCOPROTEIN A; LECTIN RECEPTOR; METALLOPROTEINASE; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ADAPTIVE IMMUNITY; ANTIFUNGAL SUSCEPTIBILITY; ANTIGEN RECOGNITION; ASPERGILLUS; CANDIDA; CELL DIFFERENTIATION; CELL VIABILITY; COCCIDIOIDES; CRYPTOCOCCUS; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; ENDOCYTOSIS; EPITHELIUM; ESCAPE BEHAVIOR; FUNGAL COLONIZATION; FUNGAL ENDOSPORE; FUNGAL SPORE GERMINATION; FUNGAL STRAIN; FUNGAL VIABILITY; FUNGAL VIRULENCE; GENETIC VARIABILITY; HISTOPLASMA CAPSULATUM; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PNEUMOCYSTIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVIEW; SURVIVAL; TH1 CELL; TH2 CELL; FUNGUS; HOST PARASITE INTERACTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MYCOSIS; PHYSIOLOGY;

FUNGI; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY, INNATE; MYCOSES;

EID: 66449094649     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780902815515     Document Type: Erratum

References (96)

1. Post MJ, Lass-Floerl C, Gastl G, Nachbaur D. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: A single-center study of 166 transplanted patients. Transpl Infect Dis 2007; 9: 189-195.
2. Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol 2007; 45: 305-320.
3. Nobile CJ, Andes DR, Nett JE, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006; 2: 63.
4. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006; 5: 1604-1610.
5. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-36.
6. Nobile CJ, Mitchell AP.Microbial biofilms: E pluribus unum. Curr Biol 2007; 17: R349-53.
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
8. Beutler B, Rietschel ET. Innate immune sensing and its roots: The story of endotoxin. Nat Rev Immunol 2003; 3: 169-176.
9. Netea MG, Brown GD, Kullberg BJ, Gow NA. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008; 6: 67-78.
10. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4: 1-23.
11. Netea MG, Gow NA, Munro CA, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116: 1642-1650.
12. Tada H, Nemoto E, Shimauchi H, et al. Saccharomyces cerevisiaeand Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol 2002; 46: 503-512.
13. Villamon E, Gozalbo D, Roig P, et al. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 2004; 6: 1-7.
14. Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059-3069.
15. Netea MG, Sutmuller R, Hermann C, et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004; 172: 3712-3718.
16. Netea MG, Van Der Graaf CA, Vonk AG, et al. The role of tolllike receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002; 185: 1483-1489.
17. Murciano C, Villamon E, Gozalbo D, et al. Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol 2006; 44: 149-157.
18. Netea MG, van de Veerdonk F, Verschueren I, van der Meer JW, Kullberg BJ. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. FEMS Immunol Med Microbiol 2008; 52: 118-123.
19. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Tolllike receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320-39326.
20. Wang JE, Warris A, Ellingsen EA, et al. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun 2001; 69: 2402-2406.
21. Netea MG, Warris A, Van der Meer JW, et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003; 188 320-326.
22. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001; 413: 36-37.
23. Brown GD, Herre J, Williams DL, et al. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003; 197: 1119-1124.
24. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. Embo J 2005 24: 1277-1286.
25. Dennehy KM, Brown GD. The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol 2007; 82: 253-258.
26. Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F. Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol 2007; 9: 368-381.
27. Taylor PR, Tsoni SV, Willment JA, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 2007; 8: 31-38.
28. Saijo S, Fujikado N, Furuta T, et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007; 8: 39-46.
29. Porcaro I, Vidal M, Jouvert S, Stahl PD, Giaimis J. Mannose receptor contribution to Candida albicans phagocytosis by murine E-clone J774 macrophages. J Leukoc Biol 2003; 74: 206-215.
30. Cambi A, Gijzen K, de Vries JM, et al. The C-type lectin DCSIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol 2003; 33: 532-538.
31. van't Wout JW, Linde I, Leijh PC, van Furth R. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol Infect Dis 1988; 7: 736-741.
32. Kullberg BJ, van't Wout JW, Poell RJ, van Furth R. Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. Antimicrob Agents Chemother 1992; 36: 1225-1229.
33. Fradin C, De Groot P, MacCallum D, et al. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 2005; 56: 397-415.
34. Ashman RB, Papadimitriou JM. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 1995; 59: 646-672.
35. Jensen J, Warner T, Balish E. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J Infect Dis 1994; 170: 900-905.
36. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982 69: 617-631.
37. Diamond RD, Krzesicki R, Jao W. Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest 1978; 61: 349-359.
38. Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 1982; 38: 487-495.
39. Christin L, Wysong DR, Meshulam T, Wang S, Diamond RD. Mechanisms and target sites of damage in killing of Candida albicans hyphae by human polymorphonuclear neutrophils. J Infect Dis 1997; 176: 1567-1578.
40. Latge JP, Mouyna I, Tekaia F, et al. Specific molecular features in the organization and biosynthesis of the cell wall of Aspergillus fumigatus. Med Mycol 2005; 43: S15-22.
41. Gow NA, Netea MG, Munro CA, et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis 2007; 196: 1565-1571.
42. Heinsbroek SE, Brown GD, Gordon S. Dectin-1 escape by fungal dimorphism. Trends Immunol 2005; 26: 352-354.
43. Kennedy AD, Willment JA, Dorward DW, et al. Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 2007]; 37: 467-478.
44. Romani L, Bistoni F, Puccetti P. Fungi, dendritic cells and receptors: A host perspective of fungal virulence. Trends Microbiol 2002; 10 508-514.
45. d'Ostiani CF, Del Sero G, Bacci A, et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000; 191: 1661-1674.
46. Rappleye CA, Eissenberg LG, Goldman WE. Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor. Proc Natl Acad Sci USA 2007; 104: 1366-1370.
47. Borges-Walmsley MI, Chen D, Shu X, Walmsley AR. The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol 2002; 10: 80-87.
48. Vecchiarelli A, Retini C, Pietrella D, et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 1995 63: 2919-2923.
49. Hung CY, Seshan KR, Yu JJ, et al. A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection. Infect Immun 2005; 73: 6689-6703.
50. Hung CY, Yu JJ, Seshan KR, Reichard U, Cole GT. A parasitic phase-specific adhesin of Coccidioides immitis contributes to the virulence of this respiratory fungal pathogen. Infect Immun 2002; 70: 3443-3456.
51. Hogan LH, Klein BS, Levitz SM. Virulence factors of medically important fungi. Clin Microbiol Rev 1996; 9: 469-488.
52. van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 2005; 73: 7458-7464.
53. Hirschfeld M, Weis JJ, Toshchakov V, et al. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001; 69: 1477-1482.
54. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276: 37692-37699.
55. Netea MG, Van der Meer JW, Sutmuller RP, Adema GJ, Kullberg BJ. From the Th1/Th2 paradigm towards a Toll-like receptor/Thelper bias. Antimicrob Agents Chemother 2005; 49: 3991-3996.
56. Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 1999; 2: 363-367.
57. Stevens DA. Th1/Th2 in aspergillosis. Med Mycol 2006; 44: 229-235.
58. Jankovic D, Liu Z, Gause WC. Th1- and Th2-cell commitment during infectious disease: Asymmetry in divergent pathways. Trends Immunol 2001; 22: 450-457.
59. Blasi E, Mucci A, Neglia R, et al. Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans. FEMS Immunol Med Microbiol 2005; 44: 69-79.
60. Vecchiarelli A, Retini C, Monari C, et al. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 1996; 64: 2846-2849.
61. Chiapello LS, Baronetti JL, Aoki MP, et al. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Immunology 2004; 113: 392-400.
62. Mednick AJ, Nosanchuk JD, Casadevall A. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect Immun 2005; 73: 2012-2019.
63. Finkel-Jimenez B, Wuthrich M, Brandhorst T, Klein BS. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J Immunol 2001; 166: 2665-2673.
64. Brandhorst TT, Wuthrich M, Finkel-Jimenez B, Warner T, Klein BS. Exploiting type 3 complement receptor for TNF-alpha suppression, immune evasion, and progressive pulmonary fungal infection. J Immunol 2004 173: 7444-7453.
65. Stringer JR, Keely SP. Genetics of surface antigen expression in Pneumocystis carinii. Infect Immun 2001; 69: 627-639.
66. Pop SM, Kolls JK, Steele C. Pneumocystis: Immune recognition and evasion. Int J Biochem Cell Biol 2006; 38: 17-22.
67. Fraser IP, Takahashi K, Koziel H, et al. Pneumocystis carinii enhances soluble mannose receptor production by macrophages. Microbes Infect 2000; 2: 1305-1310.
68. Paris S, Boisvieux-Ulrich E, Crestani B, et al. Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells. Infect Immun 1997; 65: 1510-1514.
69. Wasylnka JA, Moore MM. Uptake of Aspergillus fumigatus conidia by phagocytic and nonphagocytic cells in vitro: Quantitation using strains expressing green fluorescent protein. Infect Immun 2002; 70: 3156-3163.
70. Zhang Z, Liu R, Noordhoek JA, Kauffman HF. Interaction of airway epithelial cells (A549) with spores and mycelium of Aspergillus fumigatus. J Infect 2005; 51: 375-382.
71. Wasylnka JA, Moore MM. Aspergillus fumigatus conidia survive and germinate in acidic organelles of A549 epithelial cells. J Cell Sci 2003; 116: 1579-1587.
72. Filler SG, Sheppard DC. Fungal invasion of normally nonphagocytic host cells. PLoS Pathog 2006; 2: 129.
73. Chang YC, Stins MF, McCaffery MJ, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 2004; 72: 4985-4995.
74. Fries BC, Taborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 2001; 108: 1639-1648.
75. Tavanti A, Campa D, Bertozzi A, et al. Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection. Microbes Infect 2006; 8: 791-800.
76. Ullmann BD, Myers H, Chiranand W, et al. Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot Cell 2004; 3: 715-723.
77. Kaposzta R, Marodi L, Hollinshead M, Gordon S, da Silva RP. Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting Candida albicans. J Cell Sci 1999; 112: 3237-3248.
78. Lorenz MC, Bender JA, Fink GR. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 2004; 3: 1076-1087.
79. Richardson MD, Smith H. Resistance of virulent and attenuated strains of Candida albicans to intracellular killing by human and mouse phagocytes. J Infect Dis 1981; 144: 557-564.
80. Feldmesser M, Tucker S, Casadevall A. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 2001; 9: 273-278.
81. Goldman DL, Lee SC, Mednick AJ, Montella L, Casadevall A. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect Immun 2000; 68: 832-838.
82. Lee SC, Kress Y, Zhao ML, Dickson DW, Casadevall A. Cryptococcus neoformans survive and replicate in human microglia. Lab Invest 1995 73: 871-879.
83. Woods JP, Heinecke EL, Luecke JW, et al. Pathogenesis of Histoplasma capsulatum. Semin Respir Infect 2001; 16: 91-101.
84. Porta A, Maresca B. Host response and Histoplasma capsulatum/macrophage molecular interactions. Med Mycol 2000; 38: 399-406.
85. Strasser JE, Newman SL, Ciraolo GM, et al. Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J Immunol 1999; 162: 6148-6154.
86. Eissenberg LG, Goldman WE, Schlesinger PH. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med 1993; 177: 1605-1611.
87. Eissenberg LG, Goldman WE. Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect Immun 1987; 55 29-34.
88. Speth C, Rambach G, Lass-Florl C, Dierich MP, Wurzner R. The role of complement in invasive fungal infections. Mycoses 2004; 47: 93-103.
89. Kozel TR, Weinhold LC, Lupan DM. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect Immun 1996; 64: 3360-3368.
90. Hector RF, Yee E, Collins MS. Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect Immun 1990; 58: 1476-1478.
91. Tsai HF, Chang YC, Washburn RG, Wheeler MH, Kwon-Chung KJ. The developmentally regulated alb1 gene of Aspergillus fumigatus: Its role in modulation of conidial morphology and virulence. J Bacteriol 1998 180: 3031-3038.
92. Meri T, Hartmann A, Lenk D, et al. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun 2002; 70: 5185-5192.
93. Meri T, Blom AM, Hartmann A, et al. The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect Immun 2004; 72: 6633-6641.
94. Vogl G, Lesiak I, Jensen DB, et al. Immune evasion by acquisition of complement inhibitors: The mould Aspergillus binds both factor H and C4b binding protein. Mol Immunol 2008; 45: 1485-1493.
95. Behnsen J, Hartmann A, Schmaler J, et al. The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infect Immun 2008; 76: 820-827.
96. Kozel TR. Activation of the complement system by pathogenic fungi. Clin Microbiol Rev 1996; 9: 34-46.